The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology-Reference-Cited by-同舟云学术

The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology

Published:2022-09 Issue: Volume:153 Page:113418
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Songya,Li Jiayi,Fan Yani,Huang Tao,Zhou Yanfen,Fan Hongwei,Zhang Qi,Qiu Runze

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. Immunotherapy for Malignant Glioma: current status and future directions;Wang;Trends Pharm. Sci.,2020

2. Immune Checkpoint targeted therapy in glioma: status and hopes;Qi;Front Immunol.,2020

3. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood;Weller;Nat. Rev. Clin. Oncol.,2021

4. A potential mechanism of temozolomide resistance in glioma-ferroptosis;Hu;Front Oncol.,2020

5. Genotoxic therapy and resistance mechanism in gliomas;Lang;Pharm. Ther.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential anti‐cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research;Cancer Medicine;2024-01-17

2. Extract of Astragali Radix and Solanum nigrum Linne regulates microglia and macrophage polarization and inhibits the growth and infiltration of C6 glioblastoma;Journal of Ethnopharmacology;2024-01

3. In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs;Reviews in the Neurosciences;2023-09-01

4. Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways;International Journal of Molecular Sciences;2023-06-03

5. Calycosin protects against chronic prostatitis in rats via inhibition of the p38MAPK/NF-κB pathway;Open Medicine;2023-01-01